mPath Therapeutics manufactures and standardizes the world’s first certified all‑natural, GMP‑grade Ibogaine medicine, used to accelerate recovery from PTSD, traumatic brain injury, Parkinson’s disease, substance‑use disorders and related conditions. The treatment is delivered in a physician‑supervised hospital in Jamaica and includes comprehensive pre‑screening, a single‑session Ibogaine administration, and a 30‑day aftercare rehabilitation program to support lasting relief.
Funding
Funding not disclosed
Founders
Product
Problem
Millions of Americans experience traumatic and neurodegenerative disorders such as PTSD, traumatic brain injury, Parkinson’s disease, substance use disorder, chronic pain, depression, and anxiety, yet conventional pharmacologic and psychotherapeutic approaches often provide limited relief, high relapse rates, and significant side‑effect burdens.
Solution
mPath Therapeutics produces the world’s first certified, all‑natural, GMP‑grade ibogaine medicine and administers it in a physician‑supervised hospital environment in Jamaica. The treatment protocol begins with comprehensive medical, laboratory, and psychiatric screening to ensure patient safety. A single, controlled ibogaine session is delivered under continuous medical monitoring, leveraging the plant’s neuro‑chemical resetting properties to reduce cravings, alleviate trauma‑related symptoms, and promote neurological recovery. Following the infusion, patients participate in a structured 30‑day rehabilitation program that includes after‑care, decompression, and co‑therapy services to support integration of the experience. Ongoing support and evidence‑based therapeutic rehabilitation aim to stabilize long‑term outcomes and reduce the need for chronic medication regimens.
Target Audience
Individuals diagnosed with PTSD, traumatic brain injury, Parkinson’s disease, substance use disorders, chronic pain, depression, or anxiety who seek an evidence‑based, single‑session alternative to long‑term pharmacotherapy.
Features
- GMP‑certified, pharmaceutical‑grade ibogaine extracted from ethically sourced Tabernanthe iboga shrub
- All‑natural, plant‑based formulation with documented efficacy for PTSD, TBI, Parkinson’s, addiction, chronic pain, depression, and anxiety
- Physician‑supervised inpatient administration in a dedicated wellness hospital with continuous cardiac and psychiatric monitoring
- Comprehensive pre‑treatment diagnostics, including full blood work, cardiac screening, and psychiatric evaluation to mitigate risks
- Integrated 30‑day after‑care program offering decompression, co‑therapy, family counseling, and life‑skill support
- Standardized dosing and treatment protocol shipped from a free‑trade zone to ensure consistent product quality worldwide
- Evidence‑based follow‑up and integration services to sustain recovery and monitor long‑term health metrics